Skip to content

Clinical trials

Phase 2 Hypersensitivity trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 2 Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20091
20111
20121
20171
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aerovance, Inc.4
Cogent Biosciences, Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
AstraZeneca1
London School of Hygiene and Tropical Medicine1
Novartis Pharmaceuticals1
University of Glasgow1
University of Southampton1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity13
Asthma7
Immune System Diseases3
Eczema2
Egg Hypersensitivity2
Food Hypersensitivity2
Hematologic Diseases2
Immune Complex Diseases2
Mastocytosis2
Mastocytosis, Systemic2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.